Hesham M. Korashy

Hesham M. Korashy

  • Biography
  • Research Interest
  • Publications
  • Teaching
Copyright text here

Publications

Publications with PubMed Links

  1. Matarid TR, Rayan M, Hussein OJ, Abunada HH, Maayah ZH, Korashy HM. Exploring the link between environmental chemical exposures and epigenetic modifications in diabetes mellitus: A review. Biomol Biomed. 2025 May 1;25(12):2607-2619.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40408591
  2. Zakaria ZZ, Suleiman M, Benslimane FM, Al-Badr M, Sivaraman S, Korashy HM, Ahmad F, Uddin S, Mraiche F, Yalcin HC. Imatinib‑ and ponatinib‑mediated cardiotoxicity in zebrafish embryos and H9c2 cardiomyoblasts. Mol Med Rep. 2024 Oct;30(4):187.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/39219269
  3. Dhulkifle H, Therachiyil L, Hasan MH, Sayed TS, Younis SM, Korashy HM, Yalcin HC, Maayah ZH. Inhibition of cytochrome P450 epoxygenase promotes endothelium-to-mesenchymal transition and exacerbates doxorubicin-induced cardiovascular toxicity. Mol Biol Rep. 2024 Jul 27;51(1):859.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/39066934
  4. Dhulkifle H, Diab MI, Algonaiah M, Korashy HM, Maayah ZH. Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders. ACS Pharmacol Transl Sci. 2024 Feb 6;7(3):546-559.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38481679
  5. Rayan M, Sayed TS, Hussein OJ, Therachiyil L, Maayah ZH, Maccalli C, Uddin S, Prehn JHM, Korashy HM. Unlocking the secrets: exploring the influence of the aryl hydrocarbon receptor and microbiome on cancer development. Cell Mol Biol Lett. 2024 Mar 6;29(1):33.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38448800
  6. Therachiyil L, Peerapen P, Younis SM, Ahmad A, Thongboonkerd V, Uddin S, Korashy HM. Proteomic insight towards key modulating proteins regulated by the aryl hydrocarbon receptor involved in ovarian carcinogenesis and chemoresistance. J Proteomics. 2024 Mar 20;295:105108.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38316181
  7. Shkoor M, Jalab R, Khaled M, Shawkat TS, Korashy HM, Saad M, Su HL, Bani-Yaseen AD. Experimental and theoretical investigations of the effect of bis-phenylurea-based aliphatic amine derivative as an efficient green corrosion inhibitor for carbon steel in HCl solution. Heliyon. 2023 Sep 22;9(10):e20254.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/37780763
  8. Fernandes Q, Therachiyil L, Khan AQ, Bedhiafi T, Korashy HM, Bhat AA, Uddin S. Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells. Eur J Pharm Sci. 2023 Dec 1;191:106586.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/37729956
  9. Suleiman M, Al Najjar A, Zakaria ZZ, Ahmed R, Yalcin HC, Korashy HM, Uddin S, Riaz S, Abdulrahman N, Mraiche F. The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity. J Cardiovasc Transl Res. 2024 Apr;17(2):334-344.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/37725271
  10. Zahid MA, Abdelsalam SS, Raïq H, Parray A, Korashy HM, Zeidan A, Elrayess MA, Agouni A. Sestrin2 as a Protective Shield against Cardiovascular Disease. Int J Mol Sci. 2023 Mar 2;24(5):4880.
    PubMed Link: https://pubmed.ncbi.nlm.nih.gov/36902310